Representing leading biotech company in trademark opposition and managing large portfolio. We are assisting Andermatt with the necessary measures to protect its trademark portfolio. We are particularly tasked with the registration of the trademark PHOSBAC in class 1, which is subject to opposition from Bedson, owner of the trademark FOSBAC in class 5.
Trademarks distinguish different and unrelated products: We argue the trademarks are not similar and will not lead to confusion among consumers, besides the fact that said trademarks distinguish different products that are not related.
World leader in biological solutions: Andermatt Group is a Swiss company and a world leader in developing, producing, and distributing biological solutions. It currently markets and sells its products worldwide through its subsidiaries and more than 100 distributors.
Essential mark in client’s portfolio: PHOSBAC is an essential trademark for the client and is registered worldwide. Our strategy is to seek the registration of Andermatt’s trademark in Peru or a coexistence agreement, which is quite challenging as the objective is to enable brand registration in Peru.
Latest development: We filed the answer to the opposition within the term, and the procedure is pending at the first administrative level. We are also negotiating a coexistence agreement between the parties concerning the trademarks PHOSBAC and FOSBAC.
